The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats.
The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats.
复制标题
尼古丁代谢物可替宁可减弱谷氨酸 (NMDA) 拮抗剂对大鼠五选择系列反应时间任务 (5C-SRTT) 表现的影响。
DOI:
10.1016/j.bcp.2011.12.043
复制
发表时间:
2012
影响因子:
5.8
通讯作者:
Bartlett,MichaelG
中科院分区:
文献类型:
--
作者:
TerryJr,AlvinV;Buccafusco,JerryJ;Schade,RFoster;Vandenhuerk,Leah;Callahan,PatrickM;Beck,WayneD;Hutchings,ElizabethJ;Chapman,JamesM;Li,Pei;Bartlett,MichaelG
Cotinine, the most predominant metabolite of nicotine in mammalian species, has a pharmacological half-life that greatly exceeds its precursor. However, until recently, relatively few studies had been conducted to systematically characterize the behavioral pharmacology of cotinine. Our previous work indicated that cotinine improves prepulse inhibition of the auditory startle response in rats in pharmacological impairment models and that it improves working memory in non-human primates. Here we tested the hypothesis that cotinine improves sustained attention in rats and attenuates behavioral alterations induced by the glutamate (NMDA) antagonist MK-801. The effects of acute subcutaneous (dose range 0.03–10.0mg/kg) and chronic oral administration (2.0mg/kg/day in drinking water) of cotinine were evaluated in fixed and variable stimulus duration (VSD) as well as variable intertrial interval (VITI) versions of a five choice serial reaction time task (5C-SRTT). The results indicated only subtle effects of acute cotinine (administered alone) on performance of the 5C-SRTT (e.g., decreases in timeout responses). However, depending on dose, acute treatment with cotinine attenuated MK-801-related impairments in accuracy and elevations in timeout responses, and it increased the number of completed trials. Moreover, chronic cotinine attenuated MK-801-related impairments in accuracy and it reduced premature and timeout responses when the demands of the task were increased (i.e., by presenting VSDs or VITIs in addition to administering MK-801). These data suggest that cotinine may represent a prototype for compounds that have therapeutic potential for neuropsychiatric disorders (i.e., by improving sustained attention and decreasing impulsive and compulsive behaviors), especially those characterized by glutamate receptor alterations.
登录
查看更多内容
DOI:
10.1016/j.bbamcr.2007.12.003
发表时间:
2008-03-01
影响因子:
5.1
作者:
Rehani, Kunal;Scott, David A.;Martin, Michael
通讯作者:
Martin, Michael
DOI:
--
发表时间:
1995
期刊:
影响因子:
--
作者:
Paulson Gw;O. Bl
通讯作者:
O. Bl
影响因子:
4.7
作者:
C. Briggs;D. Mckenna
通讯作者:
D. Mckenna
DOI:
--
发表时间:
1993
期刊:
Pharmacology, Biochemistry and Behavior
影响因子:
--
作者:
A. Terry;J. Buccafusco;W. J. Jackson
通讯作者:
W. J. Jackson
DOI:
--
发表时间:
1992
期刊:
International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology
影响因子:
--
作者:
C. Halldin;K. Någren;C. Swahn;B. Långström;H. Nybäck
通讯作者:
H. Nybäck